DANA FISHER: Open Payments
NPI 1952974677 · EDISON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$993 in 50 payments from 14 companies in 2025. Trend: 2023 $274 · 2024 $304 · 2025 $993
Food & beverage: $801Education: $192
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 13 | $174 |
| Incyte Corporation | 7 | $164 |
| Janssen Biotech, Inc. | 2 | $143 |
| E.R. Squibb & Sons, L.L.C. | 7 | $115 |
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| Regeneron Healthcare Solutions, Inc. | 4 | $73 |
| ABBVIE INC. | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| GENZYME CORPORATION | 1 | $23 |
Products named: Enhertu, RYBREVANT, JAKAFI, OPDIVO, LIBTAYO, TAGRISSO, DATROWAY, IMBRUVICA.
Industry payments across NJ — which companies pay providers there.
